Dr. Martens plc (LON:DOCS - Get Free Report)'s share price hit a new 52-week high during trading on Monday . The company traded as high as GBX 94.85 ($1.29) and last traded at GBX 92.75 ($1.26), with a volume of 4064125 shares traded. The stock had previously closed at GBX 92.05 ($1.25).
Wall Street Analyst Weigh In
A number of analysts have recently weighed in on DOCS shares. Peel Hunt raised Dr. Martens to a "buy" rating in a research note on Monday, August 18th. Deutsche Bank Aktiengesellschaft reiterated a "hold" rating on shares of Dr. Martens in a report on Friday, July 11th. Finally, Royal Bank Of Canada cut their price target on shares of Dr. Martens from GBX 7,000 to GBX 6,000 and set a "sector perform" rating on the stock in a report on Monday, May 19th. One research analyst has rated the stock with a Buy rating and two have issued a Hold rating to the stock. Based on data from MarketBeat.com, the company currently has an average rating of "Hold" and an average price target of GBX 6,000.
Read Our Latest Analysis on Dr. Martens
Dr. Martens Trading Up 1.5%
The firm's fifty day moving average is GBX 83.04 and its two-hundred day moving average is GBX 67.97. The company has a quick ratio of 1.13, a current ratio of 2.85 and a debt-to-equity ratio of 127.27. The firm has a market cap of £888.41 million, a P/E ratio of 18,400.00, a PEG ratio of 6.40 and a beta of 0.11.
Insider Transactions at Dr. Martens
In related news, insider Giles Wilson acquired 105,838 shares of the stock in a transaction on Monday, September 1st. The stock was acquired at an average cost of GBX 91 per share, for a total transaction of £96,312.58. Insiders have bought 136,633 shares of company stock valued at $12,422,739 over the last ninety days. 2.76% of the stock is owned by corporate insiders.
Dr. Martens Company Profile
(
Get Free Report)
Founded in 1960, Dr. Martens is an iconic British brand with a global presence. “Docs” or “DMs” were originally
produced for their durability for workers, before being adopted by diverse youth subcultures and associated musical
movements. Today, Dr. Martens has transcended its roots while still celebrating its proud history.
Further Reading
Before you consider Dr. Martens, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Dr. Martens wasn't on the list.
While Dr. Martens currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
With the proliferation of data centers and electric vehicles, the electric grid will only get more strained. Download this report to learn how energy stocks can play a role in your portfolio as the global demand for energy continues to grow.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
